Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide
ArticleAbstract: The aim was to determine the effects of dulaglutide, a synthetic once-weekly, injectable human glucaPalabras claves:antidiabetic drug, Cardiovascular disease, Clinical trial, diabetes complications, GLP-1 receptor agonistAutores:Atisso C.M., Avezum A.J., Basile J.N., Cardona-Munoz E.G., Chung N., Colhoun H.M., Conget I., Cushman W.C., Dagenais G.R., DIaz R., Franek E., Gerstein H.C., Hâncu N., Hanefeld M., Holt S., Jansky P., Keltai M., Lakshmanan M., Lanas F., Leiter L.A., Pais P., PATRICIO LOPEZ -JARAMILLO, Pirags V., Pogosova N., Probstfield J.L., Raubenheimer P.J., Riddle M.C., Rydén L.E., Shaw J.E., Sheu W.H.H., Temelkova-Kurktschiev T., Xavier D.Fuentes:scopusThe International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct
ArticleAbstract: Background: It is hypothesized that in individuals without clinical cardiovascular disease (CVD), buPalabras claves:Autores:Bosch J.J., Dans A.M., Gamra H., Gao P., Joseph P.G., Lopez P.C., Pais P., PATRICIO LOPEZ -JARAMILLO, Santoso A., Talukder S.H., Teo K.K., Tyrwhitt J., Xavier D., Yeates K.E., Yusoff K., Yusuf S.Fuentes:googlescopus